Arkema

Arkema
Name	Arkema
Type	Public company
Industry	Chemicals
Founded	2004
Founder	TotalEnergies (spin-off origins)
Headquarters	Colombes, Hauts-de-Seine, France
Area served	Worldwide
Key people	Thierry Le Henaff
Products	Specialty chemicals, performance materials, coatings
Revenue	€ ? (see Financial Performance)
Num employees	~20,000

Arkema is a multinational specialty chemicals and materials company headquartered in Colombes, Hauts-de-Seine, France. Formed from a corporate reorganization in the early 21st century, Arkema emerged from the chemical activities of TotalEnergies to focus on value-added polymers, fluorochemicals, acrylics and industrial chemicals. The company supplies industrial customers across sectors including automotive, Construction, Aerospace, Electronics, and Healthcare with materials used in coatings, adhesives, and high-performance components.

History

Arkema originated in a restructuring that followed strategic decisions by TotalEnergies to spin off non-core industrial activities, continuing legacies from historic firms like Elf Aquitaine and Armand Peugeot-era suppliers. The 2004 establishment formalized operations previously managed under integrated petrochemical portfolios. Over subsequent decades Arkema expanded through acquisitions of specialty businesses, linking to entities such as Bostik (not to be confused with earlier adhesives houses) and portfolio companies from LyondellBasell and Huntsman Corporation. The firm navigated global events including the 2008 financial crisis, the European debt concerns of the 2010s, and the COVID-19 pandemic, adapting supply chains impacted by incidents like the 2015 Tianjin explosions and geopolitical shifts such as the Russia–Ukraine conflict that affected feedstock markets.

Operations and Products

Arkema operates manufacturing sites across Europe, North America, Asia and the Middle East, supplying sectors anchored by industrial groups like Renault, Volkswagen Group, Boeing, Airbus, and Siemens. Product lines include high-performance polymers used in 3D printing, fluorinated chemicals for refrigeration systems compatible with protocols such as the Kigali Amendment, and acrylics for architectural coatings employed on projects associated with firms like Skanska and Balfour Beatty. The company’s specialties intersect with materials developed by competitors and collaborators like BASF, Dow Chemical Company, Evonik Industries, and Solvay. Arkema’s portfolio serves markets tied to standards and consortia including ISO committees, certification bodies like Underwriters Laboratories, and industry groups such as the American Chemical Society-related networks.

Corporate Structure and Governance

Corporate governance aligns with French regulatory frameworks including listings on Euronext Paris and engagement with institutional investors like BlackRock and Vanguard. The board of directors and executive committee report under leadership including CEO Thierry Le Henaff, with oversight structures interacting with shareholder meetings, remuneration committees and auditing firms similar to partnerships seen with KPMG or Deloitte. Strategic decision-making has involved collaborations and joint ventures with multinational partners, reflecting corporate practices observed at conglomerates like Saint-Gobain and Schneider Electric.

Financial Performance

Arkema’s financial trajectory has shown revenue and margin fluctuations tied to raw material prices influenced by suppliers such as SABIC and geopolitical supply constraints stemming from events involving OPEC decisions. Earnings are reported under International Financial Reporting Standards in filings distributed to investors, with comparisons often made to peers INEOS and Mitsubishi Chemical. Capital expenditures and shareholder returns have been affected by acquisitions, divestments, and currency exposure to markets including the United States dollar and euro zone.

Research and Innovation

Research efforts are concentrated in R&D centers collaborating with academic institutions like CNRS, Sorbonne University, Massachusetts Institute of Technology, and industrial consortia including CEA initiatives. Innovation themes include low-carbon materials aligned with targets promoted at summits such as the Paris Agreement negotiations, development of bio-based polymers intersecting projects from INRAE, and advances in additive manufacturing mirrored by work at Fraunhofer Society institutes. Arkema files patents and participates in standards development alongside firms in materials research networks including European Chemical Industry Council partners.

Environmental, Health and Safety Issues

The company’s operations are regulated under European frameworks such as REACH and safety regimes influenced by incidents that reshaped industry practice after events like the Seveso disaster and the Bhopal disaster—historical precedents that inform modern risk management. Arkema reports programs to reduce greenhouse gas emissions and chemical footprints consistent with investor expectations promoted by groups such as CDP and Science Based Targets initiative. Plant-level safety involves emergency response coordination with local authorities including municipalities, regional prefectures and fire services, as seen in past industrial incidents in the chemical sector that prompted regulatory scrutiny.

Legal and Controversies

Arkema has faced litigation and regulatory inquiries typical for chemical producers, including environmental remediation responsibilities, worker safety cases, and contract disputes with industrial customers and suppliers. High-profile episodes in the sector—paralleling legal matters encountered by firms like Dupont and Bayer—have influenced compliance programs and corporate disclosure practices. Controversies have prompted engagements with courts, arbitration bodies such as International Chamber of Commerce tribunals, and regulatory agencies in jurisdictions ranging from the European Union to the United States Environmental Protection Agency.

Category:Chemical companies